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Abstract 
Background 
Although end-of-life care has become an issue of great clinical and public health concern in 
Europe and beyond, we lack population-based nationwide data that monitor and compare the 
circumstances of dying and care received in the final months of life in different countries. 
The European Sentinel GP Networks Monitoring End of Life Care (EURO SENTIMELC) 
study was designed to describe and compare the last months of life of patients dying in 
different European countries. We aim to describe how representative GP networks in the 
EURO SENTIMELC study operate to monitor end of life care in a country, to describe used 
methodology, research procedures, representativity and characteristics of the population 
reached using this methodology. 
Methods 
Nationwide representative Networks of General Practitioners (GPs) – ie epidemiological 
surveillance systems representative of all GPs in a country or large region of a country – in 
Belgium, the Netherlands, Italy and Spain continuously registered every deceased patient 
(>18 year) in their practice, using weekly standardized registration forms, during two 
consecutive years (2009–2010). 
All GPs were asked to identify patients who had died “non-suddenly”. The last three months 
of these patients’ lives was surveyed retrospectively. Several quality control measures were 
used to ensure data of high scientific quality. 
Results 
A total of 6858 deaths were registered of which two thirds died non-suddenly (from 62% in 
the Netherlands to 69% in Spain), representative for the GP populations in the participating 
countries. Of all non-sudden deaths, between 32% and 44% of deaths were aged 85 or older; 
between 46% and 54% were female, and between 23% and 49% died at home. Cancer was 
cause of death in 37% to 53% of non-sudden death cases in the four participating countries. 
Conclusion 
Via the EURO SENTI-MELC methodology, we can build a descriptive epidemiological 
database on end-of-life care provision in several EU countries, measuring across setting and 
diseases. The data can serve as baseline measurement to compare and monitor end-of-life 
care over time. The use of representative GP networks for end-of-life care monitoring has 
huge potential in Europe where several of these networks are operational. 
Keywords 
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Background 
How people die and the care delivered in the final phase of life has become an issue of great 
clinical and public health importance [1,2]. Nevertheless, population-based and nationwide 
research monitoring the circumstances surrounding death and the quality of the end-of-life 
care provided in the final months of life is limited [3-5]. Existing empirical research is often 
restricted to specific populations of patients such as cancer patients or elderly people, to 
specific settings such as hospitals, hospices, or nursing homes, or is focused on a specific 
aspect of end-of-life care provision, thus providing only a limited view on how people are 
dying in a society [6-13]. Also, research exploring large-scale databases such as disease 
registries or healthcare billing data, or once-only population-based surveys studying quality 
end-of-life care is primarily restricted to the UK, Canada and US [14-17]. 
Furthermore, comparison of practices in different countries is often not feasible due to the use 
of different methodologies in different populations. One exception concerns the international 
analyses of mortality statistics based on official death certification, showing how many 
people die, at what age, from what causes, and where [6,13], but not including important 
other parameters of the quality of end-of-life care such as the use of palliative care, 
hospitalisations and transitions between settings, or communication at the end of life. 
Gathering such epidemiological data is pivotal to developing an effective public health policy 
on end-of-life care on a national and European level [5]. 
Because the general practitioner (GP) has a pivotal role in end-of-life care delivery in most 
countries in Europe – operating across care settings and patient populations – and because 
several countries within Europe have an operating Sentinel Network of General Practitioners 
– representative of all GPs in the country or region – the EURO SENTIMELC methodology 
offers unique possibilities to describe and compare end-of-life care in Europe on a continuous 
basis [18-21]. SENTIMELC refers to „Sentinel Network Monitoring End-of-Life Care”, an 
ongoing study which first started in Belgium in 2004 and in the Netherlands in 2005 and 
since 2009–2010 also involving Italy and Spain, focusing on describing and comparing end-
of-life care in the last three months of life in different European countries – Belgium, the 
Netherlands, Italy and Spain in 2009–2010 – via the use of a representative network of GPs. 
Aims of the study 
The objective of this report is to describe how representative GP networks in the EURO 
SENTIMELC study operate to monitor end-of-life care in a country, to describe used 
methodology and research procedures, and to present representativity and characteristics of 
the population reached using this methodology in 2009 and 2010. We hope that our 
experience in these 4 EU countries will be useful to others, in particular to countries with 
analogue surveillance networks of general practitioners who wish to integrate end-of-life care 
research into their registrations. 
Methods 
Because of the problems with prognosticating who is dying in prospective end-of-life care 
research [22,23], we designed a continuous mortality follow-back study with data collection 
shortly after the patient had died, using a standardized registration form to be filled in weekly 
by the GP. The EURO SENTIMELC study was performed in 2009 and 2010 with data 
gathering in Belgium, the Netherlands, Italy and Spain (the latter limited to 2010 only). This 
European study is an expansion of the SENTIMELC study which first started in 2004 in 
Belgium and in the Netherlands in 2005 with continuing registrations since then. Several 
results for these two individual countries have been reported in previous publications 
[19,21,24-28]. In Table 1 an overview of all partners of EURO SENTIMELC is provided. 
Table 1 EURO SENTIMELC consortium 2009-2010 
 Belgium – coordinator The Netherlands Italy Spain 
Research 
institution 
VUB-UGent End-of-Life 
Care Research Group, Vrije 
Universiteit Brussel 
VU University Medical Center, 
EMGO Institute for Health and 
Care Research, Department of 
Public and Occupational Health 
ISPO, Cancer 
Prevention and 
Research Institute 
Directorate General of 
Public Health, 
Consejería de Sanidad, 
Valladolid 
GP network “Huisartsenpeilpraktijken”, 
the Belgian Sentinel Network 
of General Practitioners, 
coordinated by the Institute of 
Public Health, OD Public 
Health and Surveillance 
“Continu Morbiditeitsregistratie 
Peilstations”, the Dutch Sentinel 
Network of General 
Practitioners, coordinated by the 
NIVEL Institute 
Network from the 
Italian Society of 
General Practitioners 
Health Sentinel Network 
of Castilla y León and 
the Health Sentinel 
Network of Comunitat 
Valenciana 
Observational unit 
In this study, GPs are the observational units. Within Europe, general practice is highly 
accessible. GPs generally can provide a good public health perspective on end-of-life care 
and dying in the country. In some countries (e.g. the Netherlands, Spain), they are 
gatekeepers for healthcare delivery i.e. primary care providers who coordinate patient care 
and provide referrals to specialist services. In other countries (e.g. Belgium, Italy) they are 
not gatekeepers but do have a central coordinating role in the healthcare system with almost 
all of the population having a regular GP who they consult regularly. Hence, we use GPs in 
this study to generate a population-based sample of deaths. One important exception concerns 
the specialist nursing homes in the Netherlands since nursing home residents are treated by 
their own elderly care physicians and are thus outside of the view of the GP. Of all deaths in 
the Netherlands, 22% occurred in a nursing home in 2005 and average length of stay is more 
than one year. 
In Belgium, the Netherlands and Spain existing Sentinel Networks of General Practitioners 
(GPs) are used as the observational unit in this study. A Sentinel Network of GPs is “a 
network of practices or community based physicians who monitor one, several or an 
exhaustive list of health problems on a regular or continuing basis”. The information from 
these practices is used to monitor the health of the entire population [18,29,30]. Recorded 
data must concern an important health problem not subject to surveillance of another system, 
unless the Sentinel Network provides complementary information to this end. 
Given the existing Italian sentinel network mainly focuses on flu surveillance, the Italian 
partner has built its own GP network representative for the country and only performing 
registration regarding the end of life. To avoid selection of GPs more trained than the average 
GP in palliative care, Italian physicians were enrolled by the 9 coordinators of the 
participating health districts only specifying the procedure and not the content of the research. 
Participating physicians were sampled stratifying by age and sex, to assure representativeness 
of the GPs operating in the involved districts. Also, an extensive pilot phase was performed. 
In Belgium, the GPs have been selected to cover the whole country and form a representative 
sample of GPs in the country. Each year, the responsible Institute for Public Health monitors 
the stability of the network (there is an annual turnover of 10% on average), verifies its 
representativity comparing age, gender and geographical distribution of the sentinel GPs with 
characteristics of the total GP population in Belgium, and calculates the percentages of the 
population coverage per district. Reports are published in in Dutch and French [31]. 
In the Netherlands (with an annual turnover of less than 5%), GPs are also selected to cover 
the whole country and each year the responsible institute verifies the representativity of the 
GP sample in terms of geographical distribution, urbanization, age and gender compared with 
the total GP population. Additionally, the sample of the population reached by the sentinel 
GPs is yearly compared in terms of age and gender with the whole patient population, to 
verify the representativity of the network – which is not possible for Belgium due to the lack 
of patient lists. These data are included in the yearly reports of the Dutch sentinel practices 
[32]. 
In Spain (with an annual turnover of less than 5%), the same procedures as in the Netherlands 
are performed within the two large regions in the Centre and East of Spain (Castilla y León 
and Valencia) to ensure representativity at GP and patient level. Spanish methodologies for 
setting up the sentinel networks have previously been published [30]. Sentinel GPs are 
randomly selected into clusters of the population to have the best representativity of the 
covered population. Age and sex distribution, as well as the socioeconomic status of the 
population is periodically compared to the general population of the regions [33-35]. 
In Italy, the nine health districts in the newly set up Sentinel Network of GPs are spread all 
over the country with three of them in large metropolitan cities (Genova, Palermo, Napoli). 
GPs were found representative in terms of age and gender in all 9 health districts 
participating (distributed in all of the four Italian statistical macro-areas). The distribution by 
age, sex and calendar period (month) of deaths registered by the Network was successfully 
compared with the last available national mortality statistics (2008). 
All networks have in common that the participation of the GPs is voluntarily, and feedback is 
regularly distributed to the participants, concerned authorities, the medical press, scientific 
associations and interested individuals. The turnover of the GPs, from year to year, is low, 
which contributes to the collection of data of high scientific quality. Also, only regularly 
participating GPs (i.e. who register at least 26 weeks per year) are included for data analyses. 
Further details on the participating GP networks can be found in Table 2. 
Table 2 Characteristics of the participating GP networks in the EURO SENTIMELC 
study 2009-2010 
 Belgium The Netherlands Italy Spain 
Coordinating 
institution 
Institute of Public 
Health 
NIVEL Institute Italian Society of 
General Practitioners 
Directorate General of 
Public Health 
Founded in 1979 1970 2009 1988 
Years of participation 
in EURO 
SENTIMELC study 
Since 2004 and 
ongoing 
Since 2005 and 
ongoing 
2009 and 2010 2010 
Participating regions Country wide Country wide Country wide Castilla y León (north) 
and Valencia (south) 
Number of GP 
practices and general 
patient population 
coverage 
+/− 200 GPs 
(+/− 170 GP practices) 
Covering 1.75% of the 
total Belgian 
population 
+/−59 GPs 
(in 42 GP practices) 
Covering 0,8% of 
the total Dutch 
population 
149 GPs participating 
in 2009; and 94 GPs in 
2010 Covering +/− 3-
4% of population per 
health district 
+/−114 GPs covering 
3,5% of the total +18y 
population in Castilla y 
León; and 59 GPs 
covering 2,2% in 
Valencia 
Representativity of 
the GP network in 
the country 
Representative of all 
GPs in Belgium in 
terms of age, gender 
and geographical 
distribution, and also 
of the GPs in the 
Northern (Dutch-
speaking) and 
Southern (French-
speaking) regions 
Representative of 
all Dutch GPs in 
terms of 
geographical 
distribution and 
urbanization, age 
and gender 
Representative of all 
GPs in terms of age 
and gender in all 9 
health districts 
participating 
(distributed in all of 
the four Italian 
statistical macro-
areas) 
Representative for the 
2 participating Sentinel 
GP Networks: Castilla 
y León and Valencia, 
in terms of age, gender, 
urbanization and other 
geographical variables 
Study population 
The unit of measurement in the EURO SENTI-MELC study was the death case. Primary 
inclusion criteria were: 
– every patient, part of the practice of the GP, who had died (certified deaths and deaths of 
which they were informed afterwards) 
– aged 18 year or older 
In order to focus this study on care delivered at the end of life or on dying patients (i.e. 
patients who were theoretically able to receive care in the terminal phase of life) we 
additionally excluded all deaths that had occurred “suddenly and totally unexpectedly” for 
some research questions [20,36,37]. 
Retrospective data collection procedure 
For the purpose of this study, the GPs registered deaths via a continuous and weekly 
standardized registration form, during 2 consecutive years (2009–2010) from January 1st until 
December 31st, except for Spain that joined the study in 2010. In Italy, GPs registered via a 
web based electronic questionnaire while in all other countries GPs used paper and pencil 
(expect for Valencia that uses electronic registering). To shorten the time between death and 
registration – hence preventing recall bias as much as possible – the physicians were 
instructed to register all deaths, immediately after being informed about the patient’s death. 
GPs use patient records and information coming from hospital physicians as much as possible 
when filling in the forms. GPs are sent accompanying instructions at the beginning of each 
year, clearly stating the inclusion criteria of the study and clarifying the manner in which 
some questions need to be filled in. The specific operating procedures that are used by an 
existing Sentinel Network are also followed for the end-of-life care registration. Table 3 
provides details on the data collection procedures in each country. 
Table 3 Data collection procedures of the participating GP networks in the EURO 
SENTIMELC study 2009-2010 
Data collection 
procedures 
Belgium The Netherlands Italy Spain 
Frequency and 
mode of reporting 
Weekly reporting Paper 
and pencil 
Weekly reporting Paper 
and pencil 
Weekly reporting online web 
based registration (Emailing 
with memo sent weekly) 
No weekly reporting: deaths 
are reported the week of the 
event; however GPs are used 
to send in a weekly report 
form on other health 
problems 
    Paper and pencil for Castilly 
y Léon; electronic registry 
for Valencia 
Extra quality 
control measures 
-selection of regular 
participating GPs 
(registered 26 weeks or 
more of one year) 
-selection of regular 
participating GPs 
(registered 26 weeks or 
more of one year) 
-it concerned a new network 
only involving GPs that 
agreed to participate for a 
whole year 
-selection of regular 
participating GPs (registered 
26 weeks or more of one 
year) 
 -data entry by the Institute 
of Public Health using 
dbase-based programme to 
prevent key punching 
errors, double data entry by 
VUB 
-data entry by researchers, 
5% with double data entry 
-web based application 
needing no data entry and 
ensuring all necessary items 
are filled in 
-data entry by province 
coordinators, using dbase-
based programme to prevent 
key punching errors; no 
double data entry 
-automatic follow-up forms 
to prevent missing data for 
key variables; telephone 
contact with GP also 
possible 
-reminders send by NIVEL 
after checking for missing 
data on key variables; if 
necessary telephone 
contact with GP 
-weekly reminders (an e-mail 
with a memo was sent weekly 
to assure the ready reporting 
of deceased cases) 
-reminders to GPs when 
missing data or 
inconsistencies 
-GPs received summaries 
of all reported deaths after 
each year of registration 
(2005–2006 to verify for 
possible non-response (e.g. 
GPs who forgot to report 
one of their deaths) 
-GPs have patient lists -GPs have patient lists -GPs have patient lists 
Anonymity 
procedures 
-anonimization of patient 
data upon data entry 
-anonimization of patient 
data upon data entry 
-anonimization of patient data 
when registering 
-anonimization of patient 
data upon data entry in 
Castilla and after data 
recording in Valencia 
 -anonimization of physician 
data when closing database 
-anonimization of 
physician data when 
closing database 
-anonimization of physician 
data when closing database 
-anonimization of physician 
data when closing database 
Training for GPs -registration instructions 
each year 
-registration instructions 
each year 
-registration instructions via 
coordinating 
-registration instructions 
each year 
 -yearly individualized 
feedback on basic 
parameters 
-yearly presenting of 
results on meeting of 
participating GPs 
GPs per health district at the 
beginning of the year 
-yearly individualized 
feedback on basic 
parameters 
Definition of concepts 
In this study, we mainly focus on the final three months of life of patients and investigate 
several important components of quality of end-of-life care: places of care and death, 
transitions between care settings; communication; palliative care provision; symptoms in the 
last week of life; and costs/burden of end-of-life care. These domains have been identified in 
international literature as important components of quality of end-of-life care [15,16,38-40], 
and are particularly relevant from the GP perspective not being under surveillance via other 
instruments. 
Transitions between end-of-life care settings were defined as moves or changes in location of 
care during the last three months of life. Home (or with relatives, in service flats), care home 
(including homes for elderly people in all four countries and nursing homes in Belgium, Italy 
and Spain excluding the specialist Dutch nursing homes), hospital and inpatient palliative 
care unit, were differentiated. 
Concerning communication we differentiated between: 
– topics addressed during conversations between GP and the patient 
– elements of advance care planning: 
◦ preferences for place of death 
◦ wishes about a medical treatment s/he would or would not want in the final phase of 
life 
◦ wish for a proxy decision-maker 
 
Palliative care was studied in terms of palliative care delivered by the GP and specialist 
multidisciplinary palliative care [1]. As there are differences in the types of multidisciplinary 
palliative care services offered in each country, each service was classified into one of three 
categories in order to facilitate comparison, as shown in Table 4. 
Table 4 Specialist multidisciplinary palliative care services in the four participating 
countries of the EURO SENTIMELC study 
 Belgium Netherlands Italy Spain 
Hospice/palliative care 
unit 
Palliative care 
unit in a hospital 
Hospice, palliative 
care unit (in a 
hospital, nursing 
home, or care home) 
Hospice Palliative care unit in 
a hospital 
Palliative care service 
for patients staying at 
home 
Palliative home 
care team, 
palliative day care 
centre 
Palliative care 
consultation team* 
Palliative home care 
team, domiciliary 
integrated assistance 
with palliative care 
Palliative home care 
team, palliative day 
care centre, 
ambulatory palliative 
care in a hospital 
GP with palliative care 
training 
§
 GP with palliative 
care training† 
§
 
§
 
In-house palliative care 
service in a nursing 
home (excl. The 
Netherlands) 
Reference persons 
for palliative care 
in a nursing home 
║
 
║
 Palliative care nurses 
in a nursing home 
Hospital-based 
palliative care service 
(excl. palliative care 
unit)‡ 
Mobile palliative 
care support team 
in a hospital 
Palliative care 
consultation team* 
Pain therapy or 
palliative care 
specialist 
consultation during a 
hospital admission 
║
 
*
 Palliative care consultation teams mainly offer services to patients at home but also to patients in 
hospital/hospice/nursing home. 
†
 GPs followed palliative care training offered by the Dutch Association of General Practitioners (Nederlands 
Huisartsen Genootschap, NHG); they are registered as palliative care advisors in a central database. 
‡
 For patients admitted to hospital for at least one day in the last three months of life. 
§
 Not available/assessed in this country. 
‖
 Not available in this country. 
Measurement instrument 
A majority of the items are pooled from existing registration forms used in the SENTIMELC 
study in Belgium and the Netherlands. These were developed on the basis of previous 
retrospective and quantitative studies whenever possible [6,15,20,37,41,42]. 
In case a specific concept could not be measured with an existing instrument, questions were 
developed on the basis of relevant literature and in dialogue with the all partners (the GP 
Networks and Researchers) and a Belgian/Dutch Advisory Board consisting of GPs, 
palliative care physicians, psychologists, nurses, medical sociologists, health scientists and an 
anthropologist. Also, new questions were tested among GPs before using them. Based on our 
previous experiences with GP registrations, we mainly used structured and closed-ended 
questions. 
Questions were developed in Dutch and translated into French and English via forward-
backward procedures. Italian and Spanish versions were developed from the English version 
via the same procedures. Translations were performed by independent native-speaking 
persons and discrepancies discussed and deliberated. The translation allowed for cultural 
differences in words or health care structures (eg differences in places of care, palliative care 
services). The registration form is shown in Additional file 1 in English. 
Feasibility testing 
An extensive pilot study to test the feasibility of the study design and the measurement 
instrument was performed in Belgium in 2004 [43]. For the EURO SENTIMELC study, the 
questionnaire was pretested in all countries using the following procedures: 
a. 10–15 GPs (preferably sentinel GPs) per country were asked to fill in the registration form 
for pretesting purposes, in a face-to-face interview situation. 
b. GPs were asked to fill in two registration forms: one for the most recent sudden and totally 
unexpected death case in their GP practice; and one for the most recent non-sudden or 
expected death case in their GP practice. 
c. The physician filled in the registration form independently and without any help. 
d. All physicians were asked to report any problem (out loud) that was encountered while 
filling in the registration form, concerning eg clarity of the questions, instructions for 
filling it in, difficulty of providing the requested information etc.). The time that was 
required to fill it in was also noted. 
All issues were collected by the coordinator who made final decisions after consulting the 
partners. 
Ethical considerations 
The participating GPs were asked to give written informed consent at the beginning of a 
registration year, after being fully informed about the objectives and method of the research 
themes. If an existing GP network was used, the standard operating procedures within the 
Network were used. Additionally, strict procedures regarding patient anonymity are 
employed. Every patient that was registered within the network receives an anonymous 
reference from the GP him/herself. There also was supplementary coding of patient 
information i.e. the patient’s date of birth might be registered by the GP but was replaced 
with the patient’s age before data-entry, and postal code of habitual residence was 
transformed into more aggregate indicators such as province and region of care. Concerning 
the GPs’ identity, all his/her identification codes were replaced in the data files with 
anonymous codes during data cleaning in each country. 
The protocol of the present study was approved by the Ethical Review Board of Brussels 
University Hospital of the Vrije Universiteit Brussel and the Local Ethical Committee 
‘Comitato Etico della Azienda U.S.L. n. 9 di Grosseto’, Tuscany. According to specific 
regulations, no specific ethical approvals were needed in the Netherlands or Spain because of 
the retrospective and anonymous data collection. 
Data management and statistical analysis 
Each GP network had its own control measures to ensure data quality and to limit missing 
data (see Table 3 for details). A common format for coding of variables, used by all partners, 
was made by the coordinator, who also merged all files. All operations were stored via SPPS 
syntax-files. 
To verify if a representative population-based sample of deaths can be obtained via this 
representative sample of GPs, we evaluated whether the deaths registered by the Sentinel 
Network of GPs are comparable in terms of age, sex and place of death to the deaths 
occurring within the general population or to the characteristics of the non-sudden deaths 
within the population (if possible). 
Results 
The number of participating GPs and their population coverage per country in 2009 was 199 
(1.8%) in Belgium, 59 (0.8%) in the Netherlands, and 149 (4.3%) in Italy. The respective 
figures for 2010 were 189 (1.5%) in Belgium, 63 (0.8%) in the Netherlands, 94 (2.7%) in 
Italy, and 173 in Spain (114 (3.4%) in Castilla and León, 59 (3%) in Valencia). 
Table 5 shows the number and characteristics of the registered deaths in the EURO 
SENTIMELC study of 2009–2010 and of the percentages of nonsudden deaths in each 
country. A total of 6858 deaths were registered of which two thirds died non-suddenly (from 
62% in the Netherlands to 69% in Spain). Of these non-sudden deaths between 32% and 44% 
of deaths were aged 85 or older; between 46% and 54% were female, and between 23% and 
49% died at home. Cancer was cause of death in 37% to 53% of non-sudden death cases. 
Table 5 Number and characteristics of reported deaths in the EURO SENTIMELC 
study 2009–2010 
  Belgium The Netherlands* Italy  Spain†  
  All deaths Non-sudden 
deaths§ 
All 
deaths 
Non-sudden 
deaths§ 
All 
deaths 
Non-sudden 
deaths§ 
All 
deaths 
Non-sudden 
deaths § 
  N = 2405 N = 1604 
(66.7%) 
N = 1107 N = 635 
(62.1%) 
N = 2783 N = 1839 
(66.1%) 
N = 563 N = 388 
(68.9%) 
  % % % %† % % % % 
Age 18-64 16 14 21 18 13 13 11 11 
 65-84 47 47 50 50 48 47 46 45 
 85+ 37 39 29 32 39 40 43 44 
Gender Male 48 46 52 47 48 47 53 54 
 Female 52 54 48 53 52 53 47 46 
Place of death‡ Home 29 23 45 44 48 46 48 49 
Care or residential 
home 
27 31 14 18 7 9 11 13 
 Hospital 37 36 32 28 39 39 37 33 
 PCU/hospice 7 9 7 10 4 5 4 4 
Cause of death Cancer 28 37 37 53 34 46 35 39 
 Noncancer 72 63 63 47 66 54 65 61 
*Excluding nursing home deaths in the Netherlands. 
† Data for Spain are available only for the year 2010. 
‡IT and SP: each 1% POD elsewhere. 
§% missing on nonsudden deaths: 0.7% for Be, 0% for the Ne, 1.7% for It and 5.9% for SP. 
Percentages are rounded off hence cells may not add up to 100%. 
Table 6 also compares the characteristics of the registered sample with the characteristics of a 
reference population. In Belgium and the Netherlands, figures for all non-sudden deaths are 
compared with a previous death certificate study on end-of-life decisions (in 2007 for 
Belgium and 2005 for the Netherlands) in which a representative sample of non-sudden 
deaths was obtained after weighting [37,44]. For Italy and Spain, figures for all deaths are 
compared with the total death rates in the country or in the reference population. Overall we 
find no large differences between the obtained SENTIMELC samples and the reference 
populations. In all countries, GPs can identify deaths due to cancer and noncancer, dying at 
home as well as in institutional settings. We do see a slight underrepresentation of non-
sudden hospital deaths and people under the age of 65 in Belgium and a slight 
underrepresentation of females in the Netherlands. We assume that GPs in Spain and Italy 
might also miss out on some of the sudden deaths occurring in the hospitals, but cannot test 
this hypothesis due to the absence of place of death information on death certificates. 
Table 6 Representativitity of reported deaths in the EURO SENTIMELC study 2009–
2010 
  Belgium   The 
Netherlands 
  Italy   Spain   
  Non-
sudden 
deaths in 
the 
SENTI-
MELC 
study 
Non-
sudden 
deaths in 
the 2007 
death 
certificate 
study 
 Non-sudden 
deaths in 
the SENTI-
MELC 
study 
Non-
sudden 
deaths in 
the 2005 
death 
certificate 
study 
 All deaths 
in the 
SENTI-
MELC 
study 
All deaths 
in the 
country 
2007 
 All 
deaths 
in the 
SENTI-
MELC 
study 
All 
deaths in 
the 
regions 
2010 
 
  %* %* p** %† %† p** % % p** % % P** 
  N = 928 N = 2729  N = 635 N = 63038  N = 2783 N = 572881  N = 388 N = 
67233 
 
Age 1-64 13 16 0.01 18 21 ns 13 14 ns 11 15 ns 
 65-84 50 52  50 36  48 50  46 46  
 85+ 37 32  32 43  39 36  43 39  
Gender Male 46 47 ns 47 51 .04 48 49 ns 53 52 ns 
 Female 54 53  53 49  52 51  47 48  
Place of 
death§ 
Home 23 21 .0001 44 33 ns 48 ‡ - 48 ‡ - 
 Residential 
home 
31 25  18 16  7 ‡  11 ‡  
 Hospital 
PCU/hospice 
45 51  38 47  43 ‡  41 ‡  
* Numbers for Flanders, the Dutch-speaking part of the country (60% of the population) only, due to absence of 
death certificates database in the French-speaking part of Belgium. 
† Excluding nursing home deaths in the Netherlands. 
‡ Unknown for Italy and Spain. Although data on place of death are not available in Italy from the national 
official statistics, the results for cancer deaths were similar to the ISDOC study figures of 2003 [45]. 
§ IT and SP: each 1% POD elsewhere; BE 3% other. 
**p-values using Fisher exact test. 
Discussion 
The objectives of the EURO SENTIMELC study are to describe end-of-life care provided to 
patients who had died non-suddenly in Belgium, the Netherlands, Italy and Spain and to 
make cross-country comparisons. We also aim to investigate patient, disease and healthcare 
characteristics associated with variations in end-of-life care. To realize these objectives, this 
retrospective study with data collection via four representative Networks of General 
Practitioners was set up. 
Interpretation of the main findings 
The need for setting up standardized continuous systems to monitor where and how people 
die has been recognized worldwide [1,3-5]. The lack of population-based and nationwide 
studies on end- of-life care hampers the ability to develop an effective public health policy on 
end-of-life care and has been identified as a major gap in end-of-life research today. Also, 
improving clinical practice starts with good monitoring of the current situation [1,3-5]. 
Death certificate data or mortality statistics are by far the most known public health method 
used to inform where, at what age and due to what cause deaths occur in a country [6,46]. 
However, the resulting data are very limited in scope eg they do not included data on the 
circumstances of dying and place of death is coded in a limited way (eg in most countries 
palliative care units cannot be differentiated from hospital deaths and in some other countries 
hospital deaths can only be distinguished from deaths in ‘other places’) [46]. Several efforts 
have been made to explore data relevant for end-of-life care in existing large-scale databases 
such as disease registries, hospital discharge registers, disease-specific registers or healthcare 
billing data [7,16,17,47]. However, no data source is totally comprehensive and all have their 
specific limitations on a national and international comparative level. Tracking patients, 
cancer and non-cancer, throughout the health care systems – transferring between health care 
settings– has been found to be particularly challenging in end-of-life care research today 
[1,4,16]. Hence, using primary care GP networks that register data which is not 
systematically gathered via other data collection systems is of considerable added value for 
monitoring death and dying from a societal point of view, comparing countries and providing 
a good basis for continuous surveillance. Our results show that representative samples of GPs 
in the four countries involved have the potential of providing a good public health perspective 
on end-of-life care and dying in a country. 
This study has several potential strengths as well as limitations associated with the use of an 
(existing) surveillance network of GPs in general, and with the specific design of the study. 
Strengths 
The Sentinel Network of General Practitioners in Belgium, the Netherlands and Spain are 
representative of all GPs in the country or region, have a long tradition in scientific research, 
are flexible in terms of acceptability of new registrations, and very stable in terms of 
participating GPs. The GPs are motivated to monitor various health-related problems over 
long and repeated periods, but have not been selected on the basis of a specific interest in 
end-of-life research. In Italy, where a new network has been set up, GPs were not informed 
about the content of the research beforehand to avoid selection of GPs more trained than the 
average GP in palliative care. They were selected to be representative for 9 large health 
districts distributed all over the country. However, the GPs that are motivated to participate in 
these type of registration networks, might still represent a selective group of physicians 
interested in scientific research, a limitation that is probably also present in other studies. 
Because detailed information concerning the care provided is not always available from the 
patients’ medical files, nor from existing deaths registers such as death certificate data, a 
registration directly with GPs has important surplus value. Using the representative networks, 
we could obtain samples of deaths representative for the GP populations in the participating 
countries. A specific strength of this retrospective study is that memory bias found in other 
retrospective designs [22,36], will be limited, because of the weekly registrations, leaving 
little time between death and registration. Also, identification of non-sudden deaths as 
denominator is an advantage over other prospective and retrospective designs that have been 
criticized for selecting patients solely on the basis of diagnose or cause of death. Not all 
patients with a cancer diagnose, for example, also die of cancer or receive care with an end-
of-life intent [23,48]. By avoiding including patients that died suddenly and unexpectedly, we 
will be able to study care that was truly delivered in the context of a dying process. 
Additionally, while retrospective designs may have their limitations to resurrect certain 
aspects of the treatment histories of deceased patients [48], it is the most appropriate design 
to identify a representative sample of deaths and to make population-based estimates about 
who received palliative care [49,50]. Prospective follow-up studies cannot follow all patients 
until death hence leaving patients living the longest underrepresented [23,51]. Another 
strength concerns the possibility of making cross-country comparisons in populations 
attended by GPs and in the care provided at the end of life, using analogous methodologies. 
Finally, many different end-of-life topics can be studied via GPs. 
Weaknesses 
The registration form is to be kept simple, and time-consuming questions should be avoided 
in a surveillance system. Consequently, in-depth study of some aspects of care is generally 
not possible via this type of registration research and observed cross-country differences 
might be difficult to explain [18]. Possible weaknesses also include the retrospective data 
collection approach making reconstruction of all care provided in the final three months of 
life difficult [22] and the reliance on GPs to report care and decisions at the end of life, 
including care delivered to patients in hospitals or decisions taken by hospital physicians. An 
underestimation of specific types of care provided or decisions taken is thus possible. A 
specific weakness for Belgium is that there are no patient lists per practice, hence the 
population denominator (the “sentinel population”) is not precisely defined and has to be 
estimated on the basis of annual total number of patient encounters in the participating 
practices [52]. Additionally, while using the same methodology in the different countries, the 
population of dying patients that is taken care of by the GP differs per country – e.g. we lack 
nursing home deaths in the Netherlands – which makes it necessary to correct for these 
differences when comparing countries. Finally, GPs appear to underreport a limited number 
of deaths ie non-sudden hospital deaths and deaths of people under 65 years old in Belgium, 
and possibly also sudden hospital deaths in all countries. 
Opportunities for further research 
Because data can be gathered over time, we will, in the long-run, evaluate the monitoring 
potential of this instrument. The results could potentially serve as baseline data to monitor 
end-of-life care over time. Also, since many other European countries have at least one 
Sentinel Network of GPs [18,29], the study provides opportunities for further comparisons 
with other countries. The nationwide Sentinel Network from France has expressed interest 
and other countries are being contacted to join this monitoring study in 2013. Finally, the 
EURO SENTIMELC database is made available for the EURO IMPACT project, a EU 
funded Marie Curie Initial Training Network aimed at describing quality of end-of-life care 
for cancer and noncancer patients and identifying tools to improve it (www.euro-impact.eu) 
that is researchers will analyse and publish the obtained data. This creates important 
opportunities for large scale dissemination of the results nationally and internationally. 
Conclusions 
In the EURO SENTI-MELC study, we will build a public health database on how people are 
dying and what care they are receiving at the end of life in different countries in Europe and 
make cross-country comparisons. It will provide important information for practitioners and 
healthcare policy makers which they can use to determine their future priorities. 
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